OGEN vs USB · rev $37.7K vs P/E 12, rev $28.66B
Oragenics Inc (OGEN) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
Latest reported USB revenue for 2025-12-31 was $28.66B. Net income was $7.57B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. USB currently screens at market cap $74.68B and trailing P/E 11.9.
OGEN currently screens at market cap $2.7M. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the OGEN and USB stock pages for the full models.
Not investment advice.